Persimmon is targeting a full return to 2019 levels of new home completions in 2022.
Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Insurance Market in Poland 2020-2022, CEE Insurance Series" report has been added to ResearchAndMarkets.com's offering. The insurance market in Poland 2020-2022 is the latest full update of comprehensive publication on the insurance sector in Poland. It describes the present market structure and recent trends in the insurance market. It also provides short term estimates of the insurance premium for the years 2020-2022. By contrast, within life insurance, premium contracted by ~3% YoY, however, the fall was not directly connected to COVID-19 but rather, it was a continuation of a long-term declining trend in life insurance-based investment products suffering from increasingly restrictive regulations. Tighter regulations are also quoted among triggers of recently observed consolidation. A few new M&A deals were announced in 2020, including the withdrawal of AXA - to be acquired by Uniqa and Aegon to be purchased by VIG. Moreover, an even bigger transaction is in the cards for 2021 as Aviva considered disposing of its Polish business. The impact of COVID-19 on the insurance sector in Poland has been noticeable across various product classes e.g. falling premium in car insurance or growing premium in property/accident insurance. However, the overall effect on the sector can be assessed as close to neutral. Premium in the non-life segment remained flat in Q1-Q3 2020 if compared to the same period of the previous year.Key Topics Covered: 1. Macroeconomic Overview Poland - Overview and key factsPoland in Europe: Number of households vs. wealth, 2019Key macroeconomic indicators, 2015-2020FForeign trade statistics, C/A, FDI, 2015-2020FUnemployment and salaries/wages, 2015-2020FDisposable income in households and income distribution, 2015-2020F; Income distribution 2019Consumer confidence index evolution, Dec. 2013 - Oct.2020Warsaw Stock Exchange - Turnover, Market cap. and indexes, 2014-2019Banking assets evolution, 2015-Q1 2020 2. Insurance Market Insurance Markets in CEE - Size vs. growth matrix, 2017-2019Insurance premiums per capita & premiums/GDP penetration - CEE comparison, 2019Insurance gross premiums - Local insurers (life/non-life, in EUR), 2016-2020FInsurance gross premiums - Local insurers (life/non-life, in PLN), 2016-2020FTop 10 insurance groups in Poland by total premium written, 1H 2020 (taking into account recently announced M&A)Insurance market concentration and Herfindahl-Hirschman Index (life/non-life), 1H 2019 vs. 1H 2020Current and upcoming Insurance M&A transactions in Poland, 2018-2020Own funds for life and non-life insurers, 2016-1H 2020, SCR coverage ratios, 2017-2019Number of insurance agents by type and number of sales reps (OFWCA), 2017-2019Insurance - Regulatory institutionsPrivate health Insurance - Opportunity for insurers; Premium written, 2017-2020F 3. Non-Life Insurance Non-life insurance markets in CEE - Size vs. growth matrix, 2017-2019Non-life premiums per capita & premiums/GDP penetration - CEE comparison, 2019Non-life insurance gross and net premium evolution, 2016-2020FTop 10 non-life insurance players in Poland, 1H 2020Market shares of top non-life players evolution, 2017-1H 2020Non-life premium by client segment and insurance class (car insurance vs. other), 1H 2020Non-life premium by risk class, 2018-1H 2020Sales channels of non-life insurance, 2018-2019Non-life insurers results, technical and P&L accounts (waterfall chart), 2019Non-life insurance - Profitability tree, 2016-1H 2020Non-life insurance - Claims and expense ratio evolution, 2016-1H 2020Non-life insurance - Combined ratio and its elements, 2016-1H 2020Non-life insurance - Acquisition costs evolution, 2018-1H2020, acquisition cost ratios for top non-life insurers, 2019Network multi-agents: Unilink, CUK, Conditor, LGK , Asist, Arrant, DCU etc.Current legislative initiatives affecting insurance business in Poland, 2017/2019Car insurance - Premium and no. policies evolution, MTPL, Casco, 2016-1H 2020Car insurance - Top players in MTPL and in Casco, 2018-1H 2020Car insurance - Combined ratio and its elements, MTPL and in Casco, 2018-1H 2020Car insurance - Average premium per policy for Casco and TPL, 1Q2015-3Q2020 4. Life Insurance Life insurance markets in CEE - Size vs. growth matrix, 2017-2019Life premiums per capita & premiums/GDP penetration - CEE comparison, 2019Life insurance gross and net premiums evolution, 2016-2020ETop 10 life insurance players in Poland, 1H 2020Market shares of top life players evolution, 2017-1H 2020Life premium by insurance class and segment, 1H 2020Life premium by risk class evolution, 2018-1H 2020Life insurance technical reserves evolution and structure, 2017-1H 2020Sales channels of life insurance, 2018-2019Life insurers results, Technical and P&L accounts (waterfall chart), 2019Life insurance - profitability tree, 2016-1H 2020Life insurance - acquisition costs evolution, 2018-1H 2020, acquisition cost ratios for top life insurers, 2019 5. Bancassurance Bancassurance: Premium written by bank channel (life/non-life), 2017-2019,data by KNF vs. data by PIUBancassurance: Product/class split in bank channel (life/non-life), 3Q 2020Bancassurance: Sales of investment type life products other than unit-linked, 2016-2020FBancassurance: Comparison websites and online sales sites of banks - overview, 2020 6. Top Players' Profiles 7. Forecast Companies Mentioned Allianz Zycie Polska S.A.AvivaAviva Polska - Tunz S.A.Axa Tu S.A.,Benefia Tu S.A. Vienna Insurance GroupBenefia Tunz S.A. Vienna Insurance GroupCompensa Tunz S.A.Vienna Insurance GroupConcordia Polska TuwGenerali Tu S.A.Hdi Asekuracja Tu S.ALink4 Tu S.A.MetlifeMTU Moje Towarzystwo UbezpieczenNN Tunz S.A.PZU S.A.PZU Zycie S.A.Stu Ergo Hestia S.A.Stunz Ergo Hestia S.A.TU Allianz Polska S.A.TU Compensa S.A.TU Euler Hermes S.A.TU Europa S.A.Tuir Warta S.A.Tunz Europa S.A.Tunz Warta S.A.Uniqa Tu Na Zycie S.A.Uniqa Tu S.A. For more information about this report visit https://www.researchandmarkets.com/r/hs8k9s About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Telefónica Germany/O2 chooses MATRIXX Digital Commerce Platform to deliver 4G/5G/Fixed monetization as part of operator's new, lean IT architecture.
French business activity fell to a three-month low in February, albeit not as much as initially thought, as COVID-19 restrictions weigh on the dominant service sector, a monthly survey showed on Wednesday. Data compiler IHS Markit said its Purchasing Managers' Index fell last month to 47.0 from 47.7 in January, better than an initial reading of 45.2 and bringing the index further away from the 50-point threshold dividing an expansion in activity from a contraction. IHS Markit's PMI sub-index for the service sector fell to 45.6 from 47.3, better than an initial reading of 43.6.
A record number of Ukrainians were taken to hospital with coronavirus over the past 24 hours, while the number of deaths remains consistently high, health ministry data show on Wednesday. Health Minister Maksym Stepanov said on Facebook 3,486 people were hospitalised in the past day, the highest number since the epidemic hit the country of 41 million last year. Stepanov said 7,235 new cases were registered over the past 24 hours with 185 deaths.
GOP Gov. Greg Abbott is “gambling with the health of his state and beyond,” the newspaper's editorial board warned in a scathing column.
Company Announcement 3 March 2021 Announcement No. 3 Notice convening the NKT Annual General MeetingThe Annual General Meeting of NKT A/S will be held Thursday 25 March 2021 at 3.00 p.m. (CET). In light of COVID-19 and the Danish authorities’ measures to control the risk of infection with COVID-19, the Board of Directors has decided that the Annual General Meeting of NKT this year will be held as a fully electronic general meeting.This implies that the shareholders, instead of attending the General Meeting in person, can participate and exercise their shareholders’ rights at the Annual General Meeting electronically. Attached please find invitation and agenda with the full contents of proposals and exhibits, including overview of candidates for the Board of Directors. The Chairman’s report will be available at www.nkt.com/investors after the Annual General Meeting. The NKT 2020 Annual Report and Remuneration Report can be found and printed at www.nkt.com/investors. Contact Investor Relations: Michael Nass Nielsen, Head of Investor Relations, Tel: +45 2494 1654 Press: Pelle Fischer, External Communications Lead, Tel: +45 2223 5870 Attachments NKT notice to convene Annual General Meeting Candidates for the Board of Directors - 2021 Invitation - 2021-uk Proxy and postal vote - 2021 Agenda and proposals - 2021 Remuneration Policy 2021 - Appendix Remuneration Policy 2021 - Final
Good morning, and thank you for joining us for Neuronetics' fourth-quarter 2020 conference call. Joining me on today's call are Neuronetics president and chief executive officer, Keith Sullivan; and chief financial officer, Steve Furlong.
Acts of Desperation by Megan Nolan review – learning to say noA young Irish woman looks back on a toxic relationship in an impressive first novel with a niggling strand of moralism Megan Nolan ‘captures an intense experience with clarity and style’. Photograph: Linda Nylind/The Guardian
The climate crisis can't be solved by carbon accounting tricksDisaster looms if big finance is allowed to game the carbon offsetting markets to achieve ‘net zero’ emissions Mark Carney, former governor of the Bank of England at the UN climate change conference in 2020. Photograph: Reuters
CIP St Lucia's Covid-19 Relief Bond innovation is arguably the only socially responsible investing (SRI) option in the investment migration industry.
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 3 MARCH 2021 AT 11.00 A.M. EET Enento Group Plc - Managers' transactions - Ruuska ____________________________________________ Person subject to the notification requirementName: Ruuska, JukkaPosition: Chief Executive OfficerIssuer: Enento Group PlcLEI: 743700EPLUWXE25HGM03 Notification type: INITIAL NOTIFICATIONReference number: 743700EPLUWXE25HGM03_20210302134703_20____________________________________________ Transaction date: 2021-03-01Venue not applicableInstrument type: SHAREISIN: FI4000123195Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 4740 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 4740 Volume weighted average price: 0.00 EUR ENENTO GROUP PLC For further information: Pia KatilaInvestor Relations ManagerTel. +358 10 270 7506 Distribution: Nasdaq Helsinki Major mediaenento.com/investors Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 425 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2020 was 151,3 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.
Verkkokauppa.com Oyj Stock Exchange Release March 3, 2021 at 11:00 EET Verkkokauppa.com Oyj’s Annual Report 2020 has been published Verkkokauppa.com Oyj's Annual Report 2020 has been published. The report is attached as a separate PDF file to this release and is available on the company's website at https://investors.verkkokauppa.com, in both Finnish and English. The Annual Report includes the Report of the Board of Directors, Financial Statements, Auditor's report, the Corporate Governance Statement and the Remuneration Report 2020. For the first time, Verkkokauppa.com publishes the Annual Report in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (xHTML). The ESEF report is available on the website https://investors.verkkokauppa.com/en/financial-statements as well as being attached to this release. The audit firm PricewaterhouseCoopers Oy has provided an independent auditor’s reasonable assurance report on Verkkokauppa.com’s ESEF financial statements in accordance with ISAE 3000 (Revised). For more information, please contact: Panu Porkka CEO firstname.lastname@example.org Tel. +358 10 309 5555 Mikko Forsell CFO email@example.com Tel. +358 50 434 2516 Distribution: Nasdaq Helsinki Principal media www.verkkokauppa.com Verkkokauppa.com in short Verkkokauppa.com is Finland’s most popular and most visited Finnish online retailer, with the aim to sell to products to its customer at probably always cheaper prices. Depending on the season, the Company markets, sells, and distributes some 60,000–70,000 products in 26 different main product categories through its webstore, retail stores, and network of pick-up points. The Company has four megastores: in Oulu, Pirkkala, Raisio, and Helsinki, in addition to which products can be collected at more than 3,000 pick-up points. Verkkokauppa.com was founded in 1992 and it is headquartered in Jätkäsaari, Helsinki. The Company’s shares are listed on the official list of Nasdaq Helsinki under the ticker symbol VERK. Attachments Verkkokauppa_com_ANNUAL_REPORT_2020 743700QZE6B52SHHTV75-2020-12-31
Hexatronic Group AB (publ) 556168-6360 Press Release March 3, 2021 Hexatronic resolves on new issue in kind for the acquisition of TK-KONTOR-FREITAG GmbH The Board of Directors of Hexatronic Group AB (publ) (“Hexatronic” or the “Company”) has resolved, pursuant to the authorisation granted by the annual general meeting on 7 May 2020, on an issue in kind of 90,357 ordinary shares in Hexatronic. The resolution has been adopted in accordance with the share purchase agreement which the Company has entered into for the acquisition of 75 percent of the shares in TK-KONTOR-FREITAG GmbH (“TK”), which was previously announced on 1 March 2021. The right to subscribe for the ordinary shares shall, pursuant to the share purchase agreement and the board resolution, only vest with the seller of TK and payment shall be made by the seller contributing in kind 75 percent of the shares in TK. The subscription price, which amounts to SEK 100.52 per share, corresponds to the average closing price for Hexatronic’s ordinary share on Nasdaq Stockholm during 30 days of trading before 1 March 2021. Through the new share issue, Hexatronic’s share capital increases by SEK 4,517.85 to SEK 1,905,589.05. The number of shares will after the new issue amount to 38,111,787, of which 37,751,787 are ordinary shares and 360,000 are shares of series C. The number of votes will, after the new issue, amount to 37,787,787. Gothenburg, March 3, 2021 Henrik Larsson Lyon CEO Hexatronic Group For more information, please contact: Henrik Larsson Lyon, CEO Hexatronic Group, +46 706 50 34 00 The information was submitted for publication, through the agency of the contact person set out above, at 10.00 CET on 3 March 2021. Hexatronic Group AB (publ) is a group that develops, markets and delivers products, components and system solutions with the main focus on the fiber optic market. Hexatronic offers a wide range of innovative system and product solutions mainly for passive fiber optic infrastructure with global trademarks like Matrix, Viper, Stingray, Raptor, InOne, Drytech™, Lightmate®, Skyline and Wistom®. The Group has its headquarters in Gothenburg, Sweden and has sales offices and/or subsidiaries in Sweden, Norway, Denmark, Finland, United Kingdom, Italy, Estonia, Latvia, Lithuania, Germany, China, New Zealand, US and Canada. The Group is listed on Nasdaq Stockholm under the ticker HTRO. For more information, visit www.hexatronicgroup.com. Attachment 2021-03-03 Hexatronic resolves on new issue
AuctionAuction resultsAuction date2021-03-03Settlement date2021-03-05Credit rating class1Term3mFixed purchase rate, %0.3Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0AuctionAuction resultsAuction date2021-03-03Settlement date2021-03-05Credit rating class1Term6mFixed purchase rate, %0.4Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0AuctionAuction resultsAuction date2021-03-03Settlement date2021-03-05Credit rating class2Term3mFixed purchase rate, %0.6Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0AuctionAuction resultsAuction date2021-03-03Settlement date2021-03-05Credit rating class2Term6mFixed purchase rate, %0.7Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0
Company announcement – No. 9 / 2021 Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020 Copenhagen, DK March 3, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on March 11, 2021 at 4 pm CET (10 am ET) following the announcement of results for the full year of 2020. Presenting during the call will be President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steensberg. The presentation will be followed by a Q&A session. The conference call will be conducted in English, and the dial-in numbers are: Denmark, Copenhagen.................. +45 32 720 417Denmark, tollfree......................... +80 711 246France, Paris................................+33 (0) 170 700 781Netherlands, Amsterdam...............+31 (0) 207 956 614United Kingdom........................... +44 (0) 844 481 9752United States..............................+1 646 741 3167International .............................+44 (0) 2071 928338Confirmation Code: ...................... 3077735 A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/mmc/p/7daetm5k, and will be accessible on the Investor section of Zealand’s website (www.zealandpharma.com/investor). Due to increased demand of conference call services, it could take longer to be connected to the call. Participants are advised to register for the webcast 30 minutes before the scheduled start, if possible. A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call. # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s robust pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand markets V-Go®, an all-in-one basal-bolus insulin delivery option for people with diabetes. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics.Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA). For more information about Zealand’s business and activities, please visit www.zealandpharma.com. Forward-Looking StatementsThis announcement may contain forward-looking statements, including “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, that are based on the beliefs and assumptions and on information currently available to management of Zealand, including with respect to the closing of the Offering described herein. All statements other than statements of historical fact contained in this announcement are forward-looking statements, including statements regarding the anticipated final terms of the Investment. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Zealand's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the "Risk Factors" section of the Zealand's Annual Report on Form 20-F for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and subsequent reports that Zealand filed or files with the SEC. Forward-looking statements represent Zealand's beliefs and assumptions only as of the date of this announcement. Although Zealand believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Except as required by law, Zealand assumes no obligation to publicly update any forward‐looking statements for any reason after the date of this announcement to conform any of the forward-looking statements to actual results or to changes in its expectations. For further information, please contact: Zealand Pharma Investor RelationsMaeve ConneightonArgot Partners firstname.lastname@example.org Zealand Pharma Media Relations David Rosen Argot Partnersmedia@zealandpharma.com
Nordic Bioscience A/S, a Danish company and world leader in biomarker development, announced today the signing of an investment from KKR, a leading global investment firm. KKR will acquire a minority equity stake in Nordic Bioscience from existing shareholders and will support the company in accelerating its global growth.
Exclusive Networks, the global trusted digital infrastructure specialist, today announced its appointment of international channel veteran Denis Ferrand-Ajchenbaum to lead its global vendor strategy. A highly knowledgeable channel leader, Denis brings a proven scorecard of vendor success to his role where he will be responsible for maximising the value and global penetration of existing vendor relationships while scouting and acquiring the next generation of Exclusive Networks’ trust digital infrastructure portfolio. The ex-Arrow and IBM senior executive brings over 30 years’ leadership experience and extensive C-level connections gleaned from his Silicon Valley background and presence across technology forums.
Telstra, a leading Australian telecommunications and technology company, has today published a report in partnership with Vanson Bourne, that reveals the impact of COVID-19 on European businesses, and how some are using digital transformation to pivot business models to adapt to a post-COVID world.
Galician noir: how a rainy corner of Spain spawned a new TV genre. Spanish dramas such as Money Heist have been taking the world by storm in recent years. But why are film-makers now flooding to the country’s north-west to make their shows?